humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: Authorised2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources